pretickt

ALAB financials

Astera Labs, Inc. Common Stock · end-of-day data as of Oct 16, 2026

Astera Labs, Inc. Common Stock
ALAB · $49.59B
$285.82-2.0%last 60 sessions · close Oct 16, 2026
$100.27$483.0252 weeks
Buy · 27 analystsPT $356.58 +24.8%
  • P/E vs own-9.9%
  • P/E vs sector+321.6%
  • Target upside+24.8%
  • Off 52w high-40.8%
  • Insiders-$127M
  • FCF yield+0.6%
  • Earnings in18d
  • Trendbullish
  • Sector▲ +1.1%
  • RSI37
  • MA20×50—
  • Volume1.0x
  • Support-3.5%
  • Resistance+7.5%

ALAB reported revenue of $392M for the quarter ended Jun 30, 2026 (Q2 FY2026), up 104.5% from a year earlier. It posted diluted EPS of $0.84, free cash flow of $67.21M and a net margin of 39.0%.

Valuation

  • P/E140.8x
  • P/E vs own-9.9%
  • P/E vs sector+321.6%
  • FCF yield+0.6%
  • Market cap$49.59B

Quarterly results

Q2 FY2026: Revenue +104.5% year over year, free cash flow 17.1% of revenue, operating margin 22.7%.

RevenueFree cash flow
Q3 FY2023Q4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Q2 FY2026Jun 30, 2026$392M0.84$67.21M73.3%22.7%39.0%
Q1 FY2026Mar 31, 2026$308M0.44$67.01M76.3%20.1%26.0%
Q4 FY2025Dec 31, 2025$271M0.25$76.58M75.6%24.7%16.6%
Q3 FY2025Sep 30, 2025$231M0.50$65.88M76.2%24.0%39.5%
Q2 FY2025Jun 30, 2025$192M0.29$133M75.8%20.7%26.7%
Q1 FY2025Mar 31, 2025$159M0.18$5.96M74.9%7.1%20.0%
Q4 FY2024Dec 31, 2024$141M0.14$24.25M74.0%0.1%17.5%
Q3 FY2024Sep 30, 2024$113M-0.05$46.81M77.7%-7.9%-6.7%
Q2 FY2024Jun 30, 2024$76.85M-0.05$31.14M77.9%-31.7%-9.8%
Q1 FY2024Mar 31, 2024$65.26M-0.60$228K77.4%-127.1%-142.5%
Q4 FY2023Dec 31, 2023$50.51M0.09$13.39M77.3%17.9%28.4%
Q3 FY2023Sep 30, 2023$36.93M-0.02-$1.07M76.1%-5.4%-8.5%